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IL-12 shows promise as adjuvant in vaccines 
Scientists at the University of 
Pennsylvania Schoo( of Veterinary 
Medicine and The Wistar Institute have 
shown that lnterleukin-12 (IL-12) dra­
matically enhances the effectiveness of a 
vaccine against leishmaniasis in labora­
tory mice and suggests that lL-12 may be 
extremely useful as an adjuvant in vac­
cines against other infectious diseases. 
An adjuvant is a substance that when 
added to a vaccine is capable of strength­
ening its effectiveness in protecting an 
Individual against a disease. The findings 
were published in the January t4, 1994 
issue of Science. 
''Leishmaniasis is a tropical disease 
that can cause severe disfigurement and 
even death, and in the last six years has 
been targeted by the World Health 
Organization for the development of a 
vaccine,'' says Or. Phillip Scott, assistant 
professor at the University of 
Pennsyl¥ania School of Veterinary 
Medicine and senior author of the article. 
'·Jn addi1ion, experimental infec1ions 
with the protoz.oan parasite causing this 
disease, known as Leishmania major, 
have frequently been used to understand 
basic immunologic responses associated 
with many different infec1ions." 
"IL-12 has a key role in regulating 
the immune system and may also be 
involved in several diseases." says 
Giorgio Trinchieri. M.D .. professor at 
Wistar and a discoverer of JL-12. "It 
appears that TL-12 helps to regulate 
inflammation and the immune response 
to bacteria and other infectious agents, 
and possibly to H!V.'' 
The finding is important because. 
by using llr l2, scientists may be able to 
boost immune responses to other dis­
eases. such as tuberculosis and leprosy. 
rt has even been suggested by Dr. Jonas 
Salk (Science. May 1993) that IL-12 
might be used as an adjuvant in preven­
tive or post-exposure vaccination to 
A lOS. The work of Dr. Trinchieri has 
previously shown that in a test tube IL-
12 can indeed correc1 some of the 
immunological deficiency of blood cells 
taken from HIV patients (Journal of 
Experimental Medicine. March 1992). 
and these results have recently been 
extended by a study at !he National 
Cancer Institute (Science. December 10, 
l993). Genetics Institute, Inc. in 
Massachusetts hopes to begin Phase l tri­
als of lL-12 in HIV -positive patients 
soon (Science. OcLOber 8, 1993). 
Protective immunity induced by 
vaccination is dependent upon the capac­
ity of the vaccine to elicit the appropriate 
immune response to either resist, control 
or elimina1e the pathogen (disease-caus­
ing organism). Depending upon the 
palhogen, protec1ioo may require very 
djfferent types of immune responses. 
One 1ype of immune response is associ­
ated with the development of cells that 
A veterinarian and her clients reach out 
From time to lime we repon on unusual 
activities of one of our alumnae/i. 
Following is a report oy Eileen Rowan. 
V'77, who, together with her clients. has 
reached out to the Lakota Sioux of South 
Dakota. 
It all started 4 years ago when T 
visited Taos, New Mex.ico on a skL trip. 
and began reading up on the local Pueblo 
Indian culture. We began sending feath­
ers and an occasional fur pelt to the Taos 
Pueblo Indians, for use on their Native 
American dress. lt has progressed 10 our 
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destroy the pathogen, and is referred to 
as cell-mediated immunity, while the 
other requires the production of antibod­
ies. and is known as humoral immunity. 
Tt is now known that particular 
CD4+ T cell subsets determine which 
of these responses develop following 
immunization. The CD4+ T cells that 
direct the development of cell-me-diated 
immunity are known as Th I cells, while 
those responsible for the development 
of humoral immunity are known as 
Th2 cells. 
An essential role of adjuvants in 
vaccines is to direct the development of 
these CD4+ T cell subsets, such that the 
appropriate Th subset expands and a pro­
tective immune response is generated. 
However, i.n the past it has been poorly 
understood now adjuvants perform this 
role. Based on the current study, it has 
now been established that IL-12 primes 
animals for the cell-mediated lype of 
immune response. Since elimination of 
the parasite, Leishmania. requires cell­
mediated immunity, inclusion of IL-12 
with the vaccine leads to the develop­
ment of protection. 
IL-) 2 was fi(Sl discovered at Wistar 
in the late I 980's by a research group led 
by Dr. Trinchieri, and tater was purified 
and cloned in 1989 in collaboration with 
Genetics TnstiLute. • 
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sort of adopting the Lakota Sioux of 
South Dakota. since !hey are by far the 
poorest of all our North American 
Indians. The reservation runs 85% 
unemployment and 50% welfare. There 
are no major cities anywhere close by. 
Their reservation lacks rich mineral 
deposits, and !here ts no tourism. Forget 
gambling casinos ... there is no population 
to pull from. 
So now we have an ongoing com­
mitment to send out badly needed warm 
clothes for the bitter cold winters. Old 
ski clothes are prized, and given to 
